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OBJECTIVES: We developed a prosthesis for open pleurostomy cases where pulmonary decortication is not indicated, or where 
post-pneumonectomy space infection occurs. The open pleural window procedure not only creates a large hole in the chest wall 
that is shocking to patients, also results in a permanent deformation of the thorax. prosthesis for open pleurostomy is a self-retained 
silicone tube that requires the removal of 3 cm of one rib for insertion, and acts as a mature conventional open pleural window. 
Herein, we report our 13–year experience with this device in the management of different kinds of pleural empyema.
METHODS: Forty-four consecutive patients with chronic empyema were treated. The etiology of empyema was diverse: pneumo-
nia, 20; lung resections, 12 (pneumonectomies, 7; lobectomies, 4; non-anatomical, 1); mixed-tuberculous, 6; and mixed-malignant 
pleural effusion, 6. After debridment of both pleural surfaces, the prosthesis for open pleurostomy was inserted and attached to a 
small recipient plastic bag.
RESULTS: Infection control was achieved in 20/20 (100%) of the parapneumonic empyemas, in 3/4 (75%) of post-lobectomies, 
in 6/7 (85%) of post-pneumectomies, in 6/6 (100%) of mixed-tuberculous cases, and in 4/6 (83%) of mixed-malignant cases. Lung 
re-expansion was also successful in 93%, 75%, 33%, and 40% of the groups, respectively.
CONCLUSIONS: Prosthesis for open pleurostomy insertion is a minimally invasive procedure that can be as effective as conven-
tional open pleural window for management of chronic empyemas. Thus, we propose that the use of prosthesis for open pleurostomy 
should replace the conventional method.
KEYWORDS: Open Pleural Window; Pleurostomy; Empyema; Pleural Effusion; Pulmonary Decortication. 
INTRODUCTION
Chronic empyema, regardless of its cause, usually poses 
a difficult challenge to the thoracic surgeon.1 In practice, it 
most commonly originates from pleuro-pulmonary infection, 
lung resections associated with bronchopleural fistulas, and 
complicated esophageal surgery.2,3 When there is a healthy 
lung that can be re-expanded and the patient can tolerate a 
major operation, pulmonary decortication is the treatment 
of choice, with or without the use of VATS.4-8 However, 
there are many patients for whom this operation cannot 
be indicated, and the most commonly adopted option for 
these patients is the creation of an open pleural window 
(OPW),9 an old procedure also known as pleurostoma or 
thoracostoma. Because most surgeons resect 6 cm to 20 
cm of two to four ribs,9-12,14,16,17,19 the final result is a large 
defect in the patient’s chest wall, which gives an unpleasant 
appearance. In 1997, we reported a new technique for the 
management of chronic empyema13 that seemed to be a 
good alternative to the usual OPW. In brief, we created a 
small pleural window whose dimensions are comparable 
with those of a mature conventional thoracostomy, and 
whose diameter is maintained thereafter by the insertion of 
a self-restrained tube into the drainage tract. We thus named 
this device “prosthesis for open pleurostomy” (POP). In the 
present report, we summarize our 13-year experience in our 
institution with the use of this device for management of 
chronic empyemas of varied etiology. We also present a new 
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version of the original model. This is not an experimental 
study as the technique has been approved since 199713 by 
the ethical committee, and all patients signed an informed 
consent to participate. The conventional indication of OPW 
was given to all patients, but we decided to change the 
treatment to POP management.
METHODS
The tube originally described in our first article was 
remodeled to make it lighter and to provide a more delicate 
appearance (Figure 1). In brief, it is a corrugated 10 cm long 
silicone tube (ID, 2.0 cm; OD, 2.5 cm) with three wings at its 
base. The wings should stay close to the parietal pleura, thus 
avoiding spontaneous extrusion of the tube. Externally, the 
tube has a movable ring, which is fixed to the corrugations 
closest to the chest wall, thus preventing it from falling into 
the pleural cavity. Those corrugations are fashioned in such 
a way that the ring is allowed to advance smoothly, but is not 
able to retract (“fish skin”).
More often than not, POP insertion is done under 
general endotracheal anesthesia, although some very ill 
or debilitated patients have been operated on under local 
anesthetic infiltration. A skin incision of about 4 to 5 cm is 
made, tissues are dissected, and the prosthesis is inserted 
into the pleural space after a 3 cm segment of the rib closest 
to the most dependent portion of the empyematic cavity 
is resected (Figure 2). The appropriate site for insertion 
can be determined by chest X-rays and CT scans, finger 
palpation through a pre-existing chest tube tract, or by 
brief thoracoscopic visualization either using the video 
thoracoscope or a Carlens’ mediastinoscope. Sometimes, 
it is necessary to provide partial debridement of the pleural 
content and pleural surfaces, which can also be easily 
accomplished by thoracoscopy.
In all patients, there was an underlying parenchymal 
process limiting compliance, the complete debridement of 
the visceral and parietal pleura was impossible, and chronic 
drainage was necessary. After the POP was in place and 
secured by the external ring, its excess was trimmed away 
leaving only 2 cm of the tube out of the incision. Usually, 
one or two stitches were used to close the skin on each 
side of the tube. No bandages were necessary, and a small 
recipient plastic bag was adapted around the external end of 
the tube. After discharge, patients were advised to change the 
bag daily and to wash the pleural cavity with saline if there 
was copious purulent secretion but no bronchopleural fistula. 
After that, a small dressing was applied, and the wound was 
left to close much like wounds of ordinary chest tubes.
From September 1995 through December 2006, 44 
patients with chronic empyema who were not suitable for 
pulmonary decortication were treated by this method and 
followed until July 2007. Two additional patients have been 
treated to date, but the follow-up was too short, thus they 
were not included in this paper. There were 34 males and 
10 females (78% and 22%) whose age ranged from 16 to 
79 years (mean, 45.9 + 8.3 yrs). The etiology of empyemas 
was: parapneumonic in 20 (45%), post-lung resection in 12 
(27%), mixed-tuberculous in 6 (14%), and mixed-malignant 
in 6 (14%).
RESULTS
Given the heterogeneity of our patients and the etiology 
of their empyemas, we report the results for each group 
separately. No surgical complications were specifically 
related to this method.
Figure 1 - Photograph of the device
Figure 2 - Schematic representation of POP and its fixation after a 3 cm 
segment of a rib had been removed
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Parapneumonic Empyemas
THE complete control of pleural infection was achieved 
in all 20 patients of this group after a mean period of 206 
days of drainage with POP (range, 80 to 408 days). In 14 
of the 15 survivors (93%), there was also complete lung 
re-expansion. A typical example of such cases is presented 
in Figure 3.
In one patient, a 63-year old man, the tube remained in 
place after 350 days due to incomplete lung re-expansion. 
Five patients died due to their primary diseases (systemic 
lupus, 1; carcinomatosis, 1; lung abscess, 1; chronic 
obstructive lung disease, 1; massive pneumonia, 1), but 
without pleural sepsis, after a mean drainage period of 91 
days (range, 63 to 147 days). 
Post-Lung Resection Empyemas
Of these 12 cases, four occurred after a lobectomy 
(bronchiectasis, 1; lung cancer, 1; aspergiloma, 1; metastatic 
thymoma, 1), one after a non-anatomical resection of a 
congenital lung cyst, and seven after a pneumonectomy: 
six on the right (lung cancer, 2; bronchiectasis, 3; pleural 
mesothelioma, 1), and one on the left (tuberculosis). None of 
these 12 patients developed signs of bronchopleural fistula; 
however, after a non-anatomical resection, three of the four 
post-lobectomy empyema patients as well as the one with 
empyema achieved both complete lung re-expansion and 
resolution of the empyema after a mean drainage period 
of 197 days (range: 58 to 570 days). One patient with 
pleural empyema after a lobectomy for aspergiloma had to 
undergo complete pneumonectomy associated with muscle 
flap transposition in order to achieve definitive control of 
the infection. POP was utilized as a bridge between this 
major operation and an additional one in five of the seven 
post-pneumonectomy empyema patients. Those patients 
were later submitted either to thoracomyoplasty (2 cases) 
or thoraco-omentoplasty (3 cases) when their empyematic 
cavity was considered sufficiently clean. In those cases, 
open drainage with POP was maintained for a mean period 
of 581 days (range: 253 to 1095 days), although infection 
control was achieved sooner. Delays in surgery occurred 
due to individual particularities. In the meantime, patients 
stayed at home and were able to improve their nutritional 
and psychological status before undergoing the next major 
operation. One of the seven pneumonectomy patients (with 
bronchiectasis) achieved complete control of the pleural 
infection, but died of pulmonary embolism 46 days after POP 
insertion. The patient with pleural mesothelioma died 67 
days after drainage with POP due to cancer dissemination.
Mixed-Tuberculous Empyemas
These six patients had tuberculous effusion complicated 
by secondary infection. In all six, pleural sepsis was 
controlled after open pleural drainage with POP was 
instituted. In two, complete lung re-expansion occurred 
after a drainage period of 180 and 571 days, respectively. 
Two other patients with complete empyema control are still 
under drainage (for 60 and 756 days, respectively) due poor 
lung expansion arising from extensive disease and scarring. 
Another patient of this subset underwent a successful 
procedure similar to Clagett’s. Thus, his pleurostoma was 
surgically closed after the remaining clean cavity was filled 
with saline and neomycin 126 days after drainage with POP. 
The last patient in this group died of progressive tuberculosis 
and respiratory insufficiency 160 days after being drained 
with POP in place.
Figure 3 - A: Massive parapneumonic empyema in the right hemithorax. Although adequately drained, the lung did not re-expand and there was some 
remaining air-fluid. B: CT-scan four months after POP insertion. The lung has been completely re-expanded. POP was removed at this occasion. C: Chest 
X-Ray one month after POP removal
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Mixed-Malignant Empyemas
This group included six patients with infected malignant 
pleural effusions secondary to cancer of varied origin: breast, 
4; esophagus, 1; stomach, 1. After being drained with POP, 
complete infection control was achieved in four patients. In 
two, there was also complete pulmonary re-expansion, and 
POP was removed after 38 days and 67 days, respectively. 
Two other patients underwent a successful procedure similar 
to Clagett’s as mentioned above, after 148 days and 258 
days of drainage. One esophagectomy patient died due to 
systemic complications 11 days after POP insertion. In this 
case, neither lung re-expansion nor empyema cure could be 
evaluated. The last patient of this group died due to gastric 
cancer dissemination 158 days after drainage. At that time, 
POP was still in place, but pulmonary re-expansion was still 
incomplete.
COMMENTS
Although there are some variations in skin incisions used 
by different surgeons,9-11,14,16,17,19 the open pleural window 
is always recommended to be made wide for three main 
reasons: first, to enable debridement and promote ample 
drainage of the pleural cavity; second, to allow frequent 
irrigation and packing of the purulent surface; and third, 
because a small pleurostoma tends to close with time due 
to scarring and chest wall shrinkage. Eloesser (1935),14 one 
of the first proponents of the OPW, resected 6 cm of three 
ribs; Clagett and Geraci,15 who revived this operation in the 
early 1960s, also resected 6 cm of two or three ribs. From 
the more recent literature, Postmus et al.16 resected 8 cm of 
two to three ribs; Galvin et al.,17 Hurvitz and Tucker18 and 
Jacques and Deslauriers9 resected 10 cm of two ribs; and 
Weissberger19 resected 15 to 20 cm of three or four ribs.
Although effective for the treatment of chronic 
empyemas, the resulting major resection of the chest wall 
induced by open pleural windows should, in our opinion, 
be avoided, especially considering the current popularity 
of minimally invasive operations.5,7,8,9,21 The gross defect 
generated by the conventional OPW gives such a marred 
appearance to patients who more often than not become 
quite disappointed postoperatively. Most nurses and interns 
of our hospital also consider this to be an outdated and 
difficult operation. 
Thus, the senior author (LTBF) of the present study 
visualized the benefit of POP and reasoned that if a 
pleurostoma is larger than necessary and shrinks with time, 
it would be best to fabricate a dedicated tube that would 
maintain the necessary orifice for long term drainage (a 
mature pleurostoma) from the beginning. Complete pleural 
debridement can be easily accomplished by thoracoscopy at 
the time of POP insertion and repeated afterwards as many 
times as needed.5,7,8 POP also allows intermittent or continuous 
irrigation of the pleural cavity when indicated. Additionally, 
large OPWs have also been associated with other major 
complications such as herniation of abdominal content.20
In the present study, treatment of chronic empyemas with 
POP provided the same results we used to observe when 
performing the large OPW, both in terms of infection control 
and lung re-expansion. The use of this new device, however, 
offers additional advantages over the conventional operation: 
1) insertion takes only about 20 minutes, compared with 
at least 60 minutes usually necessary to create a large 
pleurostoma; 2) it can be done under local anesthesia; 3) 
it does not require multiple postoperative dressings or the 
close attention of nurses. The main advantage for the patient, 
however, is that the use of POP precludes major chest wall 
demolition, thus avoiding gross aesthetic compromise. 
(Figure 4).
Figure 4 - On the left, a conventional open pleural window scar in a male patient. On the right, the upper scar is after POP removal, and below is a scar 
after removal of a regular 36FR chest tube
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When the patient has a re-expandable lung, it will 
gradually replenish the whole pleural cavity in about 2 to 6 
months. In this case, the tube is removed during the patient’s 
next visit to the clinic, after applying a careful rotation and a 
gentle pull on the tube in the outpatient clinic. 
Another indication for POP was found for critically ill or 
debilitated patients who were in need of an OPW, but who 
could not tolerate the extent of the conventional procedure, 
especially the general anesthesia. POP can be performed 
with sedation and local anesthesia.
In patients with post-pneumonectomy empyema and in 
those for whom the lung cannot re-expand completely, even 
after many months of open drainage, POP has been used as 
a temporary measure. In cases where a thoracoplasty or a 
thoracomyoplasty could be anticipated,22-24 POP acted as a 
bridge between the acute state and the definitive operation. 
Moreover, prolonged drainage with POP usually favors a 
significant reduction of the empyematic cavity, thus allowing 
performance of a less extensive operation. Nonetheless, 
these are still major procedures that may represent a 
threat to senior or debilitated patients. Therefore, in cases 
where clinical conditions or patient’s refusal precludes 
such operations, it is our impression that a permanent 
pleurostomy, as provided by POP, could be a safer option. 
We did not use specific quality of life questionnaires to 
evaluate the results of this operation, but rather compared 
it with the classical treatment (OPW), the appearance was 
better and the patients and family expressed satisfaction with 
the “POP” prosthesis and because it was easier to carry out 
normal activities. 
Finally, we would like to state that our only intention 
in presenting this report was to demonstrate that chronic 
empyemas can now be treated with a much less invasive and 
non-deforming operation, with the same result as with the 
conventional technique.
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